<DOC>
	<DOCNO>NCT00032058</DOCNO>
	<brief_summary>RATIONALE : Imaging procedure magnetic resonance imaging ( MRI ) magnetic resonance spectroscopic imaging ( MRSI ) may improve ability detect extent prostate cancer . It yet know MRI combine MRSI effective MRI alone detect extent prostate cancer . PURPOSE : Diagnostic trial compare effectiveness combine MRI MRSI MRI alone determine extent prostate cancer patient schedule undergo surgery remove prostate gland .</brief_summary>
	<brief_title>Magnetic Resonance Imaging Magnetic Resonance Spectroscopic Imaging Diagnosing Extent Disease Patients With Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare accuracy MRI v MRI combine magnetic resonance spectroscopic imaging ( MRSI ) localization prostate cancer prior radical prostatectomy patient stage I II adenocarcinoma prostate . - Compare incremental benefit test diagnostic accuracy patient . - Compare incremental benefit MRSI interobserver agreement v MRI alone localization prostate cancer patient . - Compare accuracy combine MRSI available information tumor extent derive digital rectal exam , PSA level , Gleason score , Partin nomogram patient . OUTLINE : This multicenter study . At least 6 week biopsy , patient undergo MRI magnetic resonance spectroscopic imaging ( MRSI ) approximately 1 hour . Within 6 month MRI/MRSI , patient undergo radical prostatectomy . PROJECTED ACCRUAL : A total 134 patient accrue study within 7 month .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm stage III adenocarcinoma prostate At least 6 week since prior biopsy Scheduled undergo radical prostatectomy within 6 month MRI magnetic resonance spectroscopic imaging ( MRSI ) PATIENT CHARACTERISTICS : Age : 18 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Cardiovascular : No cardiac pacemaker Other : Must willing able undergo MRI/MRSI No allergy latex No contraindication MRI noncompatible intracranial vascular clip No metallic hip implant metallic implant device would compromise quality MRI/MRSI No contraindication intolerance endorectal coil insertion ( e.g. , prior abdominoperineal resection rectum Crohn 's disease ) No general medical psychiatric condition physiologic status unrelated prostate cancer would preclude valid informed consent PRIOR CONCURRENT THERAPY : Biologic therapy : No prior BCG bladder cancer Chemotherapy : Not specify Endocrine therapy : No prior androgendeprivation therapy Radiotherapy : No prior prostatic rectal radiotherapy Surgery : See Disease Characteristics No prior cryosurgery No prior surgery prostate cancer No prior transurethral resection prostate ( TURP ) No prior rectal surgery Other : No prior complementary alternative medicine</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2005</verification_date>
	<keyword>adenocarcinoma prostate</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
</DOC>